Long-term survivors of primary central nervous system lymphoma-Reference-Cited by-同舟云学术

Long-term survivors of primary central nervous system lymphoma

Published:2016-11-23 Issue:2 Volume:47 Page:101-107
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Yamanaka Ryuya¹²,Morii Ken³,Sano Masakazu¹⁴,Homma Jumpei¹⁵,Yajima Naoki¹,Tsukamoto Yoshihiro¹,Ogura Ryouske¹,Natsumeda Manabu¹,Aoki Hiroshi¹,Akiyama Katsuhiko⁶,Saitoh Takafumi⁷,Hondoh Hiroaki⁵,Kawaguchi Atsushi⁸,Takahashi Hitoshi⁹,Fujii Yukihiko¹

Affiliation:

1. Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata

2. Laboratory of Molecular Target Therapy for Cancer, Graduate School for Medical Science, Kyoto Prefectural University of Medicine, Kyoto

3. Department of Neurosurgery, Kitanihon Neurosurgical Hospital, Gosen

4. Department of Neurosurgery, Shibata Prefectural Hospital, Shibata

5. Department of Neurosurgery, Toyama Prefectural Central Hospital, Toyama

6. Department of Neurosurgery, Uonuma-Kikan Hospital, Minamiuonuma

7. Department of Neurosurgery, Nagano Red Cross Hospital, Nagano

8. Center for Comprehensive Community Medicine, Faculty of Medicine, Saga University, Saga

9. Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan

Funder

Collaborative Research Project

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/47/2/101/26368065/hyw171.pdf

Reference26 articles.

1. Trends in survival from primary central nervous system lymphoma, 1975–1999: a population-based analysis;Panageas;Cancer,2005

2. Therapeutic challenges in primary CNS lymphoma;Morris;Lancet Neurol,2009

3. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial;Ferreri;Lancet,2009

4. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial;Thiel;Lancet Oncol,2010

5. Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome;Morris;J Clin Oncol,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant;Neurology;2023-08-15

2. Seizures in patents with primary central nervous system lymphoma: Prevalence and associated features;Journal of the Neurological Sciences;2019-05

3. Management of primary central nervous system lymphoma;La Presse Médicale;2018-11

4. Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring;BioMed Research International;2018-06-21

5. Primary central nervous system lymphoma: time for diagnostic biomarkers and biotherapies?;Current Opinion in Neurology;2017-12